Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

AKRO holding history

Akero Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of AKRO by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−685,842−100.0%Sold outHolders
Q3 2025685,842$32.6M<0.1%−483,840−41.4%ReducedHolders
Q2 20251,169,682$62.4M0.1%−739,648−38.7%ReducedHolders
Q1 20251,909,330$77.3M0.1%+554,437+40.9%AddedHolders
Q4 20241,354,893$37.7M<0.1%+1,204,992+803.9%AddedHolders
Q3 2024149,901$4.30M<0.1%−245,216−62.1%ReducedHolders
Q2 2024395,117$9.27M<0.1%−24,543−5.8%ReducedHolders
Q1 2024419,660$10.6M<0.1%−65,365−13.5%ReducedHolders
Q4 2023485,025$11.3M<0.1%+182,438+60.3%AddedHolders
Q3 2023302,587$15.3M<0.1%−23,305−7.2%ReducedHolders
Q2 2023325,892$15.2M<0.1%−529,816−61.9%ReducedHolders
Q1 2023855,708$32.7M<0.1%+593,991+227.0%AddedHolders
Q4 2022261,717$14.3M<0.1%+84,556+47.7%AddedHolders
Q3 2022177,161$6.03M<0.1%+78,551+79.7%AddedHolders
Q2 202298,610$932.0K<0.1%+10,800+12.3%AddedHolders
Q1 202287,810$1.25M<0.1%+60,371+220.0%AddedHolders
Q4 202127,439$580.0K<0.1%−5,430−16.5%ReducedHolders
Q3 202132,869$735.0K<0.1%−25,193−43.4%ReducedHolders
Q2 202158,062$1.44M<0.1%−82,813−58.8%ReducedHolders
Q1 2021140,875$4.09M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.